Cargando…
Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
Nonalcoholic fatty liver disease (NAFLD) is a continuum of liver abnormalities often starting as simple steatosis and to potentially progress into nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma. Because of its increasing prevalence, NAFLD is becoming a major pu...
Autores principales: | Berardo, Clarissa, Di Pasqua, Laura Giuseppina, Cagna, Marta, Richelmi, Plinio, Vairetti, Mariapia, Ferrigno, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766139/ https://www.ncbi.nlm.nih.gov/pubmed/33348908 http://dx.doi.org/10.3390/ijms21249646 |
Ejemplares similares
-
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2022) -
Changes in Glutathione Content in Liver Diseases: An Update
por: Vairetti, Mariapia, et al.
Publicado: (2021) -
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis
por: Ferrigno, Andrea, et al.
Publicado: (2020) -
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress
por: Palladini, Giuseppina, et al.
Publicado: (2019) -
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV
por: Berardo, Clarissa, et al.
Publicado: (2020)